1,3-DIIODO-5,5-DIMETHYLHYDANTOIN
Modify Date: 2024-01-01 17:26:15
1,3-DIIODO-5,5-DIMETHYLHYDANTOIN structure
|
Common Name | 1,3-DIIODO-5,5-DIMETHYLHYDANTOIN | ||
|---|---|---|---|---|
| CAS Number | 2232-12-4 | Molecular Weight | 379.922 | |
| Density | 2.7±0.1 g/cm3 | Boiling Point | 298.4±23.0 °C at 760 mmHg | |
| Molecular Formula | C5H6I2N2O2 | Melting Point | 198°C(dec.)(lit.) | |
| MSDS | Chinese USA | Flash Point | 134.2±22.6 °C | |
| Symbol |
GHS03, GHS05, GHS09 |
Signal Word | Danger | |
| Name | 1,3-diiodo-5,5-dimethylimidazolidine-2,4-dione |
|---|---|
| Synonym | More Synonyms |
| Density | 2.7±0.1 g/cm3 |
|---|---|
| Boiling Point | 298.4±23.0 °C at 760 mmHg |
| Melting Point | 198°C(dec.)(lit.) |
| Molecular Formula | C5H6I2N2O2 |
| Molecular Weight | 379.922 |
| Flash Point | 134.2±22.6 °C |
| Exact Mass | 379.851837 |
| PSA | 40.62000 |
| LogP | 2.67 |
| Vapour Pressure | 0.0±0.6 mmHg at 25°C |
| Index of Refraction | 1.743 |
| Storage condition | -20°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Symbol |
GHS03, GHS05, GHS09 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H272-H314-H400 |
| Precautionary Statements | P220-P273-P280-P305 + P351 + P338-P310 |
| Personal Protective Equipment | Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
| RIDADR | UN 3085 5.1/PG 2 |
| RTECS | MU0970000 |
| HS Code | 2933990090 |
|
~46%
1,3-DIIODO-5,5-... CAS#:2232-12-4 |
| Literature: Raab, Conrad E.; Dean, Dennis C.; Melillo, David G. Journal of Labelled Compounds and Radiopharmaceuticals, 2001 , vol. 44, # 12 p. 815 - 829 |
| Precursor 1 | |
|---|---|
| DownStream 1 | |
CAS#:7553-56-2| HS Code | 2933990090 |
|---|---|
| Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
Evaluation of ERG and SPINK1 by Immunohistochemical Staining and Clinicopathological Outcomes in a Multi-Institutional Radical Prostatectomy Cohort of 1067 Patients.
PLoS ONE 10 , e0132343, (2015) Distinguishing between patients with early stage, screen detected prostate cancer who must be treated from those that can be safely watched has become a major issue in prostate cancer care. Identifica... |
|
|
Adenosine A2A receptor plays an important role in radiation-induced dermal injury.
FASEB J. 30 , 457-65, (2016) Ionizing radiation is a common therapeutic modality and following irradiation dermal changes, including fibrosis and atrophy, may lead to permanent changes. We have previously demonstrated that occupa... |
|
|
Duffy antigen receptor for chemokines mediates chemokine endocytosis through a macropinocytosis-like process in endothelial cells.
PLoS ONE 6 , e29624, (2012) The Duffy antigen receptor for chemokines (DARC) shows high affinity binding to multiple inflammatory CC and CXC chemokines and is expressed by erythrocytes and endothelial cells. Recent evidence sugg... |
| Hydantoin,1,3-diiodo-5,5-dimethyl |
| 1,3-Diiodo-5,5-dimethyl hydantoin |
| 1,3-diiodo-5,5-dimethylhydantion |
| N,N'-diiodo-5,5-dimethylhydantoin |
| 2,4-Imidazolidinedione,1,3-diiodo-5,5-dimethyl |
| 1,3-Diiodo-5,5-dimethylimidazolidine-2,4-dione |
| MFCD00020867 |
| 2,4-Imidazolidinedione, 1,3-diiodo-5,5-dimethyl- |
| 1,3-DIIODO-5,5-DIMETHYLHYDANTOIN |
| 1,3-Diiodo-5,5-dimethyl-2,4-imidazolidinedione |